Literature DB >> 26429329

A review of 42 cases of intestinal pseudo-obstruction in patients with systemic lupus erythematosus based on case reports.

Peng Jin1, Xiaoyan Ji2, Haining Zhi3, Xiaodong Song3, Haiwei Du3, Kai Zhang3, Rongjiang Shao3, Shanyi Ge3, Qinghai Chen3, Hongliang Lu3, Junhua Lu3.   

Abstract

Intestinal pseudo-obstruction (IpsO) is considered a severe manifestation of systemic lupus erythematosus (SLE) characterized by clinical and radiological evidence of intestinal obstruction with no identifiable mechanical lesion. We performed a systematic review to document IpsO in SLE. Twenty-eight articles with 42 patients were included. The median age of onset of IpsO was 27.5 (10-57) years. The female to male ratio was 38:4. Twenty-two (52.4%) patients had IpsO as the initial presentation of their underlying lupus. Three (7.1%) patients manifested in inactive lupus. The duration of abdominal symptoms before admitted ranged from 3 days to 3 years, however most of the patients responded well to systemic corticosteroid or immunosuppressive treatment within 2 days to about 3 months. Concomitant ureterohydronephrosis was present in approximately three-fourths of the cases. More interestingly, 4 patients presented hepatobiliary dilatation without mechanical obstruction together with IPO and ureterohydronephrosis. In conclusion, IpsO is an uncommon but important manifestation of SLE. The finding of coexisting ureterohydronephrosis and hepatobiliary dilatation suggests that there may be generalized visceral muscle dysmotility. Early recognition of IpsO is necessary to institute appropriate medical treatment and to avoid inappropriate surgical intervention.
Copyright © 2015 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Diagnose; Intestinal pseudo-obstruction; Systemic lupus erythematosus; Treatment

Mesh:

Substances:

Year:  2015        PMID: 26429329     DOI: 10.1016/j.humimm.2015.09.022

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  4 in total

1.  Intestinal pseudo-obstruction in systemic lupus erythematosus: an analysis of nationwide inpatient sample.

Authors:  Jiayi Zheng; Ruoning Ni; Hongli Liu
Journal:  Clin Rheumatol       Date:  2022-07-11       Impact factor: 3.650

2.  The Association of Coloproctology of Great Britain and Ireland consensus guidelines in emergency colorectal surgery.

Authors:  Andrew S Miller; Kathryn Boyce; Benjamin Box; Matthew D Clarke; Sarah E Duff; Niamh M Foley; Richard J Guy; Lisa H Massey; George Ramsay; Dominic A J Slade; James A Stephenson; Phil J Tozer; Danette Wright
Journal:  Colorectal Dis       Date:  2021-02       Impact factor: 3.917

3.  Lupus intestinal pseudo-obstruction and hydronephrosis: Case report.

Authors:  Brittany L Adler; Homa Timlin; Julius Birnbaum
Journal:  Medicine (Baltimore)       Date:  2019-07       Impact factor: 1.817

4.  Intestinal Pseudo-Obstruction as the Initial Clinical Presentation in Systemic Lupus Erythematosus: A Rare and Severe Disorder.

Authors:  Akwe Nyabera; Mohanad Elfishawi; Francisco Cuevas; Fahad Riaz; Adriana Abrudescu
Journal:  Case Rep Gastrointest Med       Date:  2020-11-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.